Hims & Hers Health Inc (NYSE: HIMS) open the trading on Thursday, with a bit cautious approach as it glided -5.51% to $44.06, before settling in for the price of $46.63 at the close. Taking a more long-term approach, HIMS posted a 52-week range of $18.33-$72.98.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 17.22%. Meanwhile, its Annual Earning per share during the time was 17.22%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.27%. This publicly-traded company’s shares outstanding now amounts to $217.38 million, simultaneously with a float of $203.00 million. The organization now has a market capitalization sitting at $9.96 billion. At the time of writing, stock’s 50-day Moving Average stood at $51.39, while the 200-day Moving Average is $46.31.
Hims & Hers Health Inc (HIMS) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Hims & Hers Health Inc’s current insider ownership accounts for 10.19%, in contrast to 77.70% institutional ownership. According to the most recent insider trade that took place on Oct 27 ’25, this organization’s Chief Legal Officer sold 2,637 shares at the rate of 50.10, making the entire transaction reach 132,114 in total value, affecting insider ownership by 158,493.
Hims & Hers Health Inc (HIMS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.13 per share during the current fiscal year.
Hims & Hers Health Inc’s EPS increase for this current 12-month fiscal period is 7.27% and is forecasted to reach 0.77 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 24.88% through the next 5 years, which can be compared against the 17.22% growth it accomplished over the previous five years trading on the market.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Let’s observe the current performance indicators for Hims & Hers Health Inc (HIMS). It’s Quick Ratio in the last reported quarter now stands at 4.46. Alongside those numbers, its PE Ratio stands at $55.14, and its Beta score is 2.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.95. Similarly, its price to free cash flow for trailing twelve months is now 85.50.
In the same vein, HIMS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.80, a figure that is expected to reach 0.09 in the next quarter, and analysts are predicting that it will be 0.77 at the market close of one year from today.
Technical Analysis of Hims & Hers Health Inc (HIMS)
[Hims & Hers Health Inc, HIMS] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 3.64% While, its Average True Range was 30.80.
Raw Stochastic average of Hims & Hers Health Inc (HIMS) in the period of the previous 100 days is set at 11.06%, which indicates a major rise in contrast to 0.05% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.62 that was higher than 3.57 volatility it exhibited in the past 100-days period.
